Advanced liver damage in hepatitis C patients underestimated and underdiagnosed grossly The number of hepatitis C patients experiencing advanced liver damage may be grossly underestimated and underdiagnosed, according to a study led by researchers at Henry Ford Health System and the U ed drugs .S. Centers for Disease Prevention and Control. The findings were the result of a study of 10 nearly,000 patients experiencing hepatitis C, and could have a significant effect on patient treatment and healthcare plan regarding the persistent disease. ‘Knowledge of the prevalence of liver damage will help decision making relating to screening for the consequences of hepatitis C, when to start out anti-viral therapy, and the need for follow-up counseling,’ says Stuart Gordon, M.D., lead researcher and Director of Hepatology at Henry Ford Hospital.

The method is more sensitive to changes in cancers growth also, making it possible to search for small treatment effects. Most invasive breasts cancers are thought to build up from DCIS, and regular care is to remove the entire area involved, Borowsky said. Predicated on the appearance of a DCIS under the microscope, doctors can estimate how it might become a more intense quickly, invasive form if not removed, he said. The brand new Family pet technology allows researchers to check out the same adjustments in a mouse without operation. Not only can we see the DCIS-like lesion, but we can detect the earliest transition to an invasive tumor, Borowsky stated.